Medline's fourth quarter revenue grew 14.8% to $7.8B, but net income fell 38% due to higher costs.

Medline reported fourth quarter 2025 revenue of $7.8 billion, a 14.8% increase year-over-year, while net income declined 37.7% to $180 million. For the full year 2025, revenue increased 11.5% to $28.4 billion with net income down 3.6% to $1.2 billion.

Key Highlights

• Fourth quarter net sales increased 14.8% to $7.8 billion, driven by a 14.4% rise in organic sales from higher volumes.
• Net income for the quarter decreased 37.7% to $180 million, attributed to higher cost of goods sold from tariffs and increased operating expenses, including IPO-related costs.
• The company introduced full year 2026 guidance, expecting organic sales growth between 8% and 9% and Adjusted EBITDA of $3.5 billion to $3.6 billion.